In last trading session, ProPhase Labs Inc (NASDAQ:PRPH) saw 1.49 million shares changing hands with its beta currently measuring -0.52. Company’s recent per share price level of $0.45 trading at $0.08 or 22.74% at ring of the bell on the day assigns it a market valuation of $13.53M. That closing price of PRPH’s stock is at a discount of -1562.22% from its 52-week high price of $7.48 and is indicating a premium of 51.11% from its 52-week low price of $0.22. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.97 million shares which gives us an average trading volume of 9.72 million if we extend that period to 3-months.
For ProPhase Labs Inc (PRPH), analysts’ consensus is at an average recommendation of Hold while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 0 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.24 in the current quarter.
ProPhase Labs Inc (NASDAQ:PRPH) trade information
Upright in the green during last session for gaining 22.74%, in the last five days PRPH remained trading in the green while hitting it’s week-highest on Wednesday, 03/12/25 when the stock touched $0.45 price level, adding 2.15% to its value on the day. ProPhase Labs Inc’s shares saw a change of -40.18% in year-to-date performance and have moved 8.48% in past 5-day. ProPhase Labs Inc (NASDAQ:PRPH) showed a performance of 72.53% in past 30-days. Number of shares sold short was 1.66 million shares which calculate 0.07 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 14 to the stock, which implies a rise of 96.79% to its current value. Analysts have been projecting 14 as a low price target for the stock while placing it at a high target of 14. It follows that stock’s current price would drop -3011.11% in reaching the projected high whereas dropping to the targeted low would mean a loss of -3011.11% for stock’s current value.
ProPhase Labs Inc (PRPH) estimates and forecasts
This year revenue growth is estimated to fall -71.22% from the last financial year’s standing.
1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 3.77M for the same. And 1 analysts are in estimates of company making revenue of 2.45M in the next quarter. Company posted 4.35M and 3.63M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -47.90% during past 5 years.
ProPhase Labs Inc (NASDAQ:PRPH)’s Major holders
Insiders are in possession of 11.16% of company’s total shares while institution are holding 8.99 percent of that, with stock having share float percentage of 10.12%. Investors also watch the number of corporate investors in a company very closely, which is 8.99% institutions for ProPhase Labs Inc that are currently holding shares of the company. VANGUARD GROUP INC is the top institutional holder at PRPH for having 0.66 million shares of worth $2.74 million. And as of 2024-06-30, it was holding 3.6351 of the company’s outstanding shares.
The second largest institutional holder is RENAISSANCE TECHNOLOGIES LLC, which was holding about 0.22 million shares on 2024-06-30. The number of shares represents firm’s hold over 1.222 of outstanding shares, having a total worth of $0.92 million.
On the other hand, Vanguard Total Stock Market Index Fund and Perritt Microcap Opportunities Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 454.64 shares of worth $0.21 million or 1.90% of the total outstanding shares. The later fund manager was in possession of 190.0 shares on Dec 31, 2024 , making its stake of worth around $86050.0 in the company or a holder of 0.80% of company’s stock.
